CIK 0001006281 · Non-accelerated filer<br>Smaller reporting company
Protalix BioTherapeutics, Inc.
Sign in to watch- Ticker
- PLX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650643773
- Phone
- 201-696-9345
- Business address
- 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
- Former names
- ORTHODONTIX INC, EMBASSY ACQUISITION CORP
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Regulation FD disclosure
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Insider Changes in Ownership
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure · Other events
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
Page 39 of 49 · 974 filings